Resources Contact Us Home
System and method for transmitting signals via photonic excitation of a transmitter array

Image Number 11 for United States Patent #7898464.

A radio frequency (RF) phased array transmitter system comprises a phased array for generating an RF signal. The phased array comprises conductive patches formed in an array, separation gaps, and active sources. Each of the separation gaps is formed between two adjacent ones of the conductive patches, and each of the active sources is formed across its associated one of the separation gaps. The system further comprises an optical source for generating an optical signal and an RF source for generating an RF signal. In addition, the system comprises an optical modulator coupled to the optical source and the RF source. The optical modulator receives an optical signal and an RF signal, and produces an RF modulated optical signal based on the received optical signal and the received RF signal.

  Recently Added Patents
Surround sound effects provided by cell phones
Audio and music data transmission medium and transmission protocol
Display screen with graphical user interface
Placental tissue grafts
Apparatus and method for phase synchronization in radio frequency transmitters
Method and apparatus for determining the altitude of a mobile device
Method and apparatus for modeling computer program behaviour for behavioural detection of malicious program
  Randomly Featured Patents
Image pickup apparatus
Uniform tungsten silicide films produced by chemical vapor deposition
Method and a device for the separation of sulphur dioxide from a gas
Continuously adaptive digital video compression system and method for a web streamer
Manufacture of xylitol using recombinant microbial hosts
Device for forming coils for windings for dynamo-electric machines
Valve assembly for an oscillating pump
Equipment for covering stacked goods with shrinkable hoods
Method and apparatus for detonation of distributed charges
Utilization of otilonium bromide (DCI) for topical application in the gastroinstestinal tract and related pharmaceutical formulation appropriate for such use